Last updated: 2026-10-10 20:15:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
AstraZeneca PLC (AZN) operates in the -- sector and is listed on NYSE. The stock is currently priced at $159.20, with a market capitalisation of $246.25B and a P/E ratio of 111.17. Over the past 52 weeks, its price has ranged from $153.41 to $212.71. This page covers its latest market performance, valuation, price trends and company information.
$246.25B | |
$159.45 | |
$212.71 | |
$29.96 | |
$158.78 | |
1.73M | |
3.33M | |
111.17 | |
$212.71 | |
$153.41 | |
1.43% | |
-- |
AstraZeneca PLC (AZN) last closed at $158.78 as of 2026-10-09 23:56:00, unchanged from the previous close of $158.78.
During the latest regular trading session, AZN traded between $29.96 and $212.71, with a volume of 1.73M shares. The closing price was near the upper end and near the lower end of its 52-week range.
Over the past seven days, AstraZeneca PLC (AZN) moved from $157.70 to $159.20, representing a gain of 0.95% ($1.50).
The stock traded between $154.81 and $161.33 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 2.68 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 9.8%
AZN is currently trading at $159.20, placing it 9.8% of the way from its 52-week low of $153.41 to its 52-week high of $212.71. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
| Employees | 96100 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of AstraZeneca PLC (AZN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.